TCL Archive NCI Spent $381.2 Million On PR From 2006 to 2012, Vastly Outspending Other NIH, FDA Units March 1, 2013
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive Professional Societies: ACCI Selects UPCI To Manage Operations; Elects New Officers December 3, 1999
TCL Archive Bristol No Longer Needs Yew From Public Lands, Official Says; Will Use Processed Needles January 29, 1993
TCL Archive More Debate Due On Organ Site Program; First Round Reviewed By DRG “Slaughtered” January 28, 1983